ONCY
Price
$1.06
Change
-$0.02 (-1.85%)
Updated
Sep 5 closing price
Capitalization
107.32M
66 days until earnings call
OVID
Price
$1.23
Change
-$0.06 (-4.65%)
Updated
Sep 5 closing price
Capitalization
87.46M
66 days until earnings call
Interact to see
Advertisement

ONCY vs OVID

Header iconONCY vs OVID Comparison
Open Charts ONCY vs OVIDBanner chart's image
Oncolytics Biotech
Price$1.06
Change-$0.02 (-1.85%)
Volume$269.99K
Capitalization107.32M
Ovid Therapeutics
Price$1.23
Change-$0.06 (-4.65%)
Volume$1.49M
Capitalization87.46M
ONCY vs OVID Comparison Chart in %
Loading...
ONCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OVID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ONCY vs. OVID commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ONCY is a Hold and OVID is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (ONCY: $1.06 vs. OVID: $1.23)
Brand notoriety: ONCY and OVID are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ONCY: 25% vs. OVID: 73%
Market capitalization -- ONCY: $107.32M vs. OVID: $87.46M
ONCY [@Biotechnology] is valued at $107.32M. OVID’s [@Biotechnology] market capitalization is $87.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ONCY’s FA Score shows that 0 FA rating(s) are green whileOVID’s FA Score has 1 green FA rating(s).

  • ONCY’s FA Score: 0 green, 5 red.
  • OVID’s FA Score: 1 green, 4 red.
According to our system of comparison, OVID is a better buy in the long-term than ONCY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ONCY’s TA Score shows that 5 TA indicator(s) are bullish while OVID’s TA Score has 5 bullish TA indicator(s).

  • ONCY’s TA Score: 5 bullish, 3 bearish.
  • OVID’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ONCY is a better buy in the short-term than OVID.

Price Growth

ONCY (@Biotechnology) experienced а +1.92% price change this week, while OVID (@Biotechnology) price change was -3.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ONCY is expected to report earnings on Nov 12, 2025.

OVID is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ONCY($107M) has a higher market cap than OVID($87.5M). OVID YTD gains are higher at: 31.734 vs. ONCY (15.999). ONCY has higher annual earnings (EBITDA): -30.65M vs. OVID (-41.01M). OVID has more cash in the bank: 38.3M vs. ONCY (14.6M). ONCY has less debt than OVID: ONCY (888K) vs OVID (14.1M). OVID has higher revenues than ONCY: OVID (6.65M) vs ONCY (0).
ONCYOVIDONCY / OVID
Capitalization107M87.5M122%
EBITDA-30.65M-41.01M75%
Gain YTD15.99931.73450%
P/E Ratio12.78N/A-
Revenue06.65M-
Total Cash14.6M38.3M38%
Total Debt888K14.1M6%
FUNDAMENTALS RATINGS
ONCY vs OVID: Fundamental Ratings
ONCY
OVID
OUTLOOK RATING
1..100
1344
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
25
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3634
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OVID's Valuation (25) in the Pharmaceuticals Major industry is somewhat better than the same rating for ONCY (78) in the Biotechnology industry. This means that OVID’s stock grew somewhat faster than ONCY’s over the last 12 months.

OVID's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as ONCY (100) in the Biotechnology industry. This means that OVID’s stock grew similarly to ONCY’s over the last 12 months.

OVID's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as ONCY (100) in the Biotechnology industry. This means that OVID’s stock grew similarly to ONCY’s over the last 12 months.

OVID's Price Growth Rating (34) in the Pharmaceuticals Major industry is in the same range as ONCY (36) in the Biotechnology industry. This means that OVID’s stock grew similarly to ONCY’s over the last 12 months.

OVID's P/E Growth Rating (94) in the Pharmaceuticals Major industry is in the same range as ONCY (100) in the Biotechnology industry. This means that OVID’s stock grew similarly to ONCY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ONCYOVID
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 12 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
77%
Aroon
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ONCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OVID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JAGGF3.780.18
+5.06%
Jaguar Mining Inc.
ASEKY16.84N/A
N/A
Aisin Corporation
ALSAF9.00N/A
N/A
Alpha Star Acquisition Corporation
NZTCF1.50N/A
N/A
Spark New Zealand Limited
PTEEF0.05N/A
N/A
Plaintree Systems Inc.

ONCY and

Correlation & Price change

A.I.dvisor tells us that ONCY and RIGL have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ONCY and RIGL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONCY
1D Price
Change %
ONCY100%
-1.85%
RIGL - ONCY
33%
Poorly correlated
+3.02%
OVID - ONCY
31%
Poorly correlated
-4.65%
SRRK - ONCY
30%
Poorly correlated
-3.18%
ABCL - ONCY
28%
Poorly correlated
+1.44%
LGVN - ONCY
28%
Poorly correlated
+5.84%
More

OVID and

Correlation & Price change

A.I.dvisor indicates that over the last year, OVID has been closely correlated with JBIO. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if OVID jumps, then JBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OVID
1D Price
Change %
OVID100%
-4.65%
JBIO - OVID
79%
Closely correlated
-0.13%
ARCT - OVID
46%
Loosely correlated
+6.50%
GBIO - OVID
43%
Loosely correlated
+3.63%
DNLI - OVID
42%
Loosely correlated
+4.33%
BEAM - OVID
41%
Loosely correlated
+12.62%
More